299 related articles for article (PubMed ID: 33253659)
1. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial.
Yang HK; Ji J; Han SU; Terashima M; Li G; Kim HH; Law S; Shabbir A; Song KY; Hyung WJ; Kosai NR; Kono K; Misawa K; Yabusaki H; Kinoshita T; Lau PC; Kim YW; Rao JR; Ng E; Yamada T; Yoshida K; Park DJ; Tai BC; So JBY;
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):120-127. PubMed ID: 33253659
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
Misawa K; Mochizuki Y; Sakai M; Teramoto H; Morimoto D; Nakayama H; Tanaka N; Matsui T; Ito Y; Ito S; Tanaka K; Uemura K; Morita S; Kodera Y;
Br J Surg; 2019 Nov; 106(12):1602-1610. PubMed ID: 31573086
[TBL] [Abstract][Full Text] [Related]
3. Extensive peritoneal lavage after curative gastrectomy for gastric cancer (EXPEL): study protocol of an international multicentre randomised controlled trial.
Kim G; Chen E; Tay AY; Lee JS; Phua JN; Shabbir A; So JB; Tai BC
Jpn J Clin Oncol; 2017 Feb; 47(2):179-184. PubMed ID: 28173154
[TBL] [Abstract][Full Text] [Related]
4. Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Trial.
Guo J; Xu A; Sun X; Zhao X; Xia Y; Rao H; Zhang Y; Zhang R; Chen L; Zhang T; Li G; Xu H; Xu D
JAMA Surg; 2019 Jul; 154(7):610-616. PubMed ID: 30916742
[TBL] [Abstract][Full Text] [Related]
5. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma.
Kuramoto M; Shimada S; Ikeshima S; Matsuo A; Yagi Y; Matsuda M; Yonemura Y; Baba H
Ann Surg; 2009 Aug; 250(2):242-6. PubMed ID: 19638909
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Extensive Intraperitoneal Lavage for Patients with Gastric Cancer - A Systematic Review and Meta-analysis.
Najah Q; Abdelrehim AM; Elmallahy M; Alsubayhay A; Alabdallat YJ
J Gastrointest Cancer; 2024 Mar; 55(1):96-104. PubMed ID: 37750984
[TBL] [Abstract][Full Text] [Related]
7. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial.
Kurokawa Y; Doki Y; Mizusawa J; Terashima M; Katai H; Yoshikawa T; Kimura Y; Takiguchi S; Nishida Y; Fukushima N; Iwasaki Y; Kaji M; Hirao M; Katayama H; Sasako M
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):460-468. PubMed ID: 29709558
[TBL] [Abstract][Full Text] [Related]
8. The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.
Masuda T; Kuramoto M; Shimada S; Ikeshima S; Yamamoto K; Nakamura K; Yoshimatsu S; Urata M; Baba H
Int J Clin Oncol; 2016 Apr; 21(2):289-294. PubMed ID: 26296529
[TBL] [Abstract][Full Text] [Related]
9. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
Fujitani K; Yang HK; Mizusawa J; Kim YW; Terashima M; Han SU; Iwasaki Y; Hyung WJ; Takagane A; Park DJ; Yoshikawa T; Hahn S; Nakamura K; Park CH; Kurokawa Y; Bang YJ; Park BJ; Sasako M; Tsujinaka T;
Lancet Oncol; 2016 Mar; 17(3):309-318. PubMed ID: 26822397
[TBL] [Abstract][Full Text] [Related]
10. Extensive intraperitoneal lavage to eliminate intraperitoneal tumor cells in gastrectomy with D2 lymphadenectomy for gastric cancer.
Ronellenfitsch U; Ernst K; Mertens C; Trunk MJ; Ströbel P; Marx A; Kienle P; Post S; Nowak K
Tumori; 2018 Oct; 104(5):361-368. PubMed ID: 30185117
[TBL] [Abstract][Full Text] [Related]
11. Extended intraoperative peritoneal lavage as prophylactic peritoneal recurrence for locally advanced gastric cancer: a prospective randomized trial.
Rodríguez-Santiago J; Luna A; Garsot E; Aldeano A; Balagué C; Rada A
Clin Transl Oncol; 2021 Sep; 23(9):1857-1865. PubMed ID: 33792839
[TBL] [Abstract][Full Text] [Related]
12. Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells.
Shimada S; Tanaka E; Marutsuka T; Honmyo U; Tokunaga H; Yagi Y; Aoki N; Ogawa M
Gastric Cancer; 2002; 5(3):168-72. PubMed ID: 12378344
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and outcome of extensive intraoperative peritoneal lavage plus surgery
Song ED; Xia HB; Zhang LX; Ma J; Luo PQ; Yang LZ; Xiang BH; Zhou BC; Chen L; Sheng H; Fang Y; Han WX; Wei ZJ; Xu AM
World J Gastrointest Surg; 2023 Mar; 15(3):430-439. PubMed ID: 37032799
[TBL] [Abstract][Full Text] [Related]
14. Three-year outcomes of the randomized phase III SEIPLUS trial of extensive intraoperative peritoneal lavage for locally advanced gastric cancer.
Guo J; Xu A; Sun X; Zhao X; Xia Y; Rao H; Zhang Y; Zhang R; Chen L; Zhang T; Li G; Xu H; Xu D
Nat Commun; 2021 Nov; 12(1):6598. PubMed ID: 34782599
[TBL] [Abstract][Full Text] [Related]
15. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
Noh SH; Park SR; Yang HK; Chung HC; Chung IJ; Kim SW; Kim HH; Choi JH; Kim HK; Yu W; Lee JI; Shin DB; Ji J; Chen JS; Lim Y; Ha S; Bang YJ;
Lancet Oncol; 2014 Nov; 15(12):1389-96. PubMed ID: 25439693
[TBL] [Abstract][Full Text] [Related]
17. A PHASE II TRIAL EXPLORING THE EXTENSIVE INTRA-OPERATIVE PERITONEAL LAVAGE (EIPL) AS A PROPHYLACTIC STRATEGY FOR PERITONEAL RECURRENCE IN LOCALLY ADVANCED GASTRIC CANCER: reporting postoperative morbidity and mortality after early closure.
Batista TP; Martins MR; Martins-Filho ED; Santos RL
Arq Gastroenterol; 2015; 52(2):161-4. PubMed ID: 26039838
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial.
Katai H; Mizusawa J; Katayama H; Morita S; Yamada T; Bando E; Ito S; Takagi M; Takagane A; Teshima S; Koeda K; Nunobe S; Yoshikawa T; Terashima M; Sasako M
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):142-151. PubMed ID: 31757656
[TBL] [Abstract][Full Text] [Related]
19. Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
Thuss-Patience PC; Shah MA; Ohtsu A; Van Cutsem E; Ajani JA; Castro H; Mansoor W; Chung HC; Bodoky G; Shitara K; Phillips GDL; van der Horst T; Harle-Yge ML; Althaus BL; Kang YK
Lancet Oncol; 2017 May; 18(5):640-653. PubMed ID: 28343975
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of gastrectomy for gastric cancer patients with positive lavage cytology without gross peritoneal dissemination.
Kobayashi H; Honda M; Kawamura H; Takiguchi K; Muto A; Yamazaki S; Teranishi Y; Shiraso S; Kono K; Hori S; Kamiga T; Iwao T; Yamashita N
J Surg Oncol; 2022 Mar; 125(4):615-620. PubMed ID: 34985764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
